Fidelity International’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
46,560
+2,720
| +6% | +$98K | ﹤0.01% | 705 |
|
|
2025
Q1 | $1.36M | Sell |
43,840
-4,856
| -10% | -$151K | ﹤0.01% | 704 |
|
|
2024
Q4 | $1.24M | Sell |
48,696
-3,242
| -6% | -$82.7K | ﹤0.01% | 712 |
|
|
2024
Q3 | $1.47M | Buy |
51,938
+5,319
| +11% | +$150K | ﹤0.01% | 705 |
|
|
2024
Q2 | $1.23M | Buy |
46,619
+23,638
| +103% | +$623K | ﹤0.01% | 716 |
|
|
2024
Q1 | $698K | Buy |
22,981
+1,621
| +8% | +$49.2K | ﹤0.01% | 742 |
|
|
2023
Q4 | $600K | Buy |
21,360
+1,599
| +8% | +$44.9K | ﹤0.01% | 729 |
|
|
2023
Q3 | $536K | Buy |
19,761
+1,816
| +10% | +$49.3K | ﹤0.01% | 718 |
|
|
2023
Q2 | $552K | Sell |
17,945
-1,361
| -7% | -$41.8K | ﹤0.01% | 713 |
|
|
2023
Q1 | $696K | Buy |
19,306
+11,406
| +144% | +$411K | ﹤0.01% | 730 |
|
|
2022
Q4 | $312K | Buy |
+7,900
| New | +$312K | ﹤0.01% | 748 |
|